(Q43205523)

English

Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects

scientific article published on 21 December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 November 2017

Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects (English)

1 reference

Europe PubMed Central

16 November 2017

1 reference

based on heuristic

inferred from title

Jean-Sébastien Hulot

1

1 reference

Europe PubMed Central

16 November 2017

Grégoire Wuerzner

2

1 reference

Europe PubMed Central

16 November 2017

Christilla Bachelot-Loza

object named as

C Bachelot-Loza

3

0 references

Christian Funck-Brentano

object named as

C Funck-Brentano

7

0 references

author name string

M Azizi

4

1 reference

Europe PubMed Central

16 November 2017

A Blanchard

5

1 reference

Europe PubMed Central

16 November 2017

S Peyrard

6

1 reference

Europe PubMed Central

16 November 2017

P Gaussem

8

1 reference

Europe PubMed Central

16 November 2017

publication date

21 December 2009

1 reference

Europe PubMed Central

16 November 2017

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

16 November 2017

8

1 reference

Europe PubMed Central

16 November 2017

3

1 reference

Europe PubMed Central

16 November 2017

610-613

1 reference

Europe PubMed Central

16 November 2017

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03729.X

21 January 2018

Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03729.X

21 January 2018

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03729.X

21 January 2018

Cytochrome p-450 polymorphisms and response to clopidogrel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03729.X

21 January 2018

Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03729.X

21 January 2018

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03729.X

21 January 2018

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03729.X

21 January 2018

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03729.X

21 January 2018

Can we override clopidogrel resistance?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03729.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2009.03729.X

1 reference

Europe PubMed Central

16 November 2017

1 reference

Europe PubMed Central

16 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43205523&oldid=1983819572"